NeuroD1 A45T and PAX4 R121W polymorphisms are associated with plasma glucose level of repaglinide monotherapy in Chinese patients with type 2 diabetes

MLA

Zhi-Cheng, Gong, et al. “NeuroD1 A45T and PAX4 R121W Polymorphisms Are Associated with Plasma Glucose Level of Repaglinide Monotherapy in Chinese Patients with Type 2 Diabetes.” British Journal of Clinical Pharmacology, vol. 74, no. 3, Feb. 2012. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........6a53502264a9f3580e18c042e041eb83&authtype=sso&custid=ns315887.

APA

Zhi-Cheng, G., Qiong, H., Xing-Ping, D., Guang-Hua, L., Hong-Bin, L., Ji-Ye, Y., Xiao-Jing, X., Jian, Q., Qi, P., Min, D., Bo-Ting, Z., Jie, S., Gan, Z., Hong-Hao, Z., & Zhao-Qian, L. (2012). NeuroD1 A45T and PAX4 R121W polymorphisms are associated with plasma glucose level of repaglinide monotherapy in Chinese patients with type 2 diabetes. British Journal of Clinical Pharmacology, 74(3).

Chicago

Zhi-Cheng, Gong, Huang Qiong, Dai Xing-Ping, Lei Guang-Hua, Lu Hong-Bin, Yin Ji-Ye, Xu Xiao-Jing, et al. 2012. “NeuroD1 A45T and PAX4 R121W Polymorphisms Are Associated with Plasma Glucose Level of Repaglinide Monotherapy in Chinese Patients with Type 2 Diabetes.” British Journal of Clinical Pharmacology 74 (3). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........6a53502264a9f3580e18c042e041eb83&authtype=sso&custid=ns315887.